Cresemba
Active Ingredient(s): Isavuconazonium SulfateFDA Approved: * March 6, 2015
Pharm Company: * ASTELLAS
Category: Antifungal
Isavuconazonium sulfate, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis.[7][5][6][9] The most common side effects include abnormal liver tests, nausea, vomiting, difficulty breathing, abdominal pain, diarrhea, injection site reactions, headache, low blood potassium and skin rash.[8] Isavuconazonium is a pr... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Cresemba 74.4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0469-0420
Labeler:
Astellas Pharma Us, Inc.